Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug 16:3:1270382.
doi: 10.3389/fneph.2023.1270382. eCollection 2023.

Editorial: Personalized medicine in CKD patients

Michele F Eisenga  1 , Gert Mayer  2 , Markus Pirklbauer  2 , Michele Provenzano  3
Affiliations
Editorial

Editorial: Personalized medicine in CKD patients

Michele F Eisenga et al. Front Nephrol. .
No abstract available

Keywords: nutrition; parathormone; personalized medicine; residual renal function (RRF); statin.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic Personalized medicine in CKD patients

References

    1. Peng S, Shen F, Wen A, Wang L, Fan Y, Liu X, et al. . Detecting lifestyle risk factors for chronic kidney disease with comorbidities: Association rule mining analysis of web-based survey data. J Med Internet Res (2019) 21(12):e14204. doi: 10.2196/14204 - DOI - PMC - PubMed
    1. Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Klarenbach S, et al. . Cause of death in patients with reduced kidney function. J Am Soc Nephrol (2015) 26(10):2504–11. doi: 10.1681/ASN.2014070714 - DOI - PMC - PubMed
    1. Drueke TB, Massy ZA. Atherosclerosis in CKD: differences from the general population. Nat Rev Nephrol (2010) 6(12):723–35. doi: 10.1038/nrneph.2010.143 - DOI - PubMed
    1. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, et al. . Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med (2005) 353(3):238–48. doi: 10.1056/NEJMoa043545 - DOI - PubMed
    1. Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, et al. . Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med (2009) 360(14):1395–407. doi: 10.1056/NEJMoa0810177 - DOI - PubMed

Publication types

LinkOut - more resources